GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Net Margin %

Biovica International AB (OSTO:BIOVIC B) Net Margin % : -2,543.53% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Biovica International AB's Net Income for the three months ended in Jan. 2024 was kr-27.34 Mil. Biovica International AB's Revenue for the three months ended in Jan. 2024 was kr1.08 Mil. Therefore, Biovica International AB's net margin for the quarter that ended in Jan. 2024 was -2,543.53%.

The historical rank and industry rank for Biovica International AB's Net Margin % or its related term are showing as below:

OSTO:BIOVIC B' s Net Margin % Range Over the Past 10 Years
Min: -3265.13   Med: -1814.36   Max: -245.27
Current: -1938.68


OSTO:BIOVIC B's Net Margin % is ranked worse than
79.94% of 1027 companies
in the Biotechnology industry
Industry Median: -151.78 vs OSTO:BIOVIC B: -1938.68

Biovica International AB Net Margin % Historical Data

The historical data trend for Biovica International AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Net Margin % Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Net Margin %
Get a 7-Day Free Trial Premium Member Only -717.34 -1,814.36 -1,900.96 -2,934.13 -3,265.13

Biovica International AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,081.86 -3,959.98 -1,839.45 -1,002.11 -2,543.53

Competitive Comparison of Biovica International AB's Net Margin %

For the Biotechnology subindustry, Biovica International AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Net Margin % falls into.



Biovica International AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Biovica International AB's Net Margin for the fiscal year that ended in Apr. 2023 is calculated as

Net Margin=Net Income (A: Apr. 2023 )/Revenue (A: Apr. 2023 )
=-110.492/3.384
=-3,265.13 %

Biovica International AB's Net Margin for the quarter that ended in Jan. 2024 is calculated as

Net Margin=Net Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-27.343/1.075
=-2,543.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (OSTO:BIOVIC B) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Biovica International AB Net Margin % Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB (OSTO:BIOVIC B) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines